Abstract. The majority of colon cancers develop from preexisting adenomas. We analyzed the expression profiles in the sequence of normal colon crypts, adenomas and earlystage carcinomas using microdissected cells from tubular adenomas with foci of malignant transformation. Differentially expressed genes were detected between normal-adenoma and adenoma-carcinoma, and were grouped according to the patterns of expression changes in the sequence. Down-regulated genes in the sequence included PLA2G2A, TSPAN1, PDCD4, FCGBP, AATK, EPLIN, FABP1, AGR2, MTUS1, TSC1, galectin 4 and MT1F. PLA2G2A has been shown to suppress colon tumorigenesis in mice, but the pathobiological role in humans has been controversial. Our data showed continuous down-regulation of PLA2G2A in the sequence supporting an implication in human colon cancer. Tumor suppressor and/ or proapoptotic activities have also been reported in other genes. Up-regulated genes included ribosomal proteins, IER3 and TPR. TGF-ß2 and matrix metalloproteinase 23B were up-regulated in carcinoma but not in adenoma, supporting the pathobiological roles in malignant transformation. Differentially expressed genes partly coincided with those in the adenoma-carcinoma sequence of the stomach, which was published previously, suggesting a partial overlap between the adenoma-carcinoma sequences of the colon and stomach.
Introduction
Colon cancers arise in pre-existing adenomas frequently, although alternative pathways are known to exist (1) . Multiple genetic alterations have been implicated in the adenoma-carcinoma sequence (2) . Many studies have suggested a role for uncharacterized genetic factors in predisposition to the majority of colon cancers (3) (4) (5) . Thus, expression changes in the sequence might give us an insight into the molecular carcinogenesis. Nonetheless, surprisingly little expression profiling data of the adenoma/carcinoma sequence has been reported so far. The available data mostly report the differential expression between whole tissue samples of adenoma and carcinoma from multiple individuals (6) (7) (8) (9) (10) . However, DNA microarray data using whole tissue samples of gastrointestinal tracts is particularly difficult to interpret because of considerable data noise from various inflammatory infiltration and reactive stromal changes (11) . Furthermore, potential individual variations should be considered. To avoid those problems, it would be advantageous to investigate the sequential expression changes in a given adenoma with foci of malignant transformation and adjacent normal crypts using microdissection.
Formalin-fixation and paraffin-embedding is usually required for the delineation of subtle lesions such as malignant foci developing in adenoma. It also makes retrospective studies possible using paraffin blocks in pathology files. A problem of formalin-fixation is that it causes extensive base modification of nucleic acids (12) , which makes it difficult to recover RNAs for the expression profiling. However, expression profiling of formalin-fixed tissue samples has been improved considerably (13, 14) . Recently, we reported a reproducible procedure of RNA extraction and amplification which showed differential expression in the adenomacarcinoma sequence of the stomach (15) .
The adenoma-carcinoma sequence may also be found in a group of stomach cancers (16, 17) , although it does not seem to be as frequently shown as in colon. Gastric tubular adenomas almost always develop in the background of intestinal metaplasia and often show the adenoma-carcinoma sequence reminiscent of that in the colon (Lee I, unpublished data), suggesting that similar molecular sequences of carcinogenesis might be implicated in both type of cancers.
In this study, we analyzed the expression changes in the normal-adenoma-carcinoma sequence in the colon using microdissected cells from formalin-fixed, paraffin-embedded tissues. Differentially expressed genes were categorized according to the patterns of change in the sequence. They partly coincided with those published in the adenomacarcinoma sequence of the stomach, suggesting a partial overlap between the adenoma-carcinoma sequences in the colon and stomach. The pathobiological implications of PLA2G2A and other differentially expressed genes in colon carcinogenesis are discussed.
Materials and methods
Tissue samples and microdissection. Two colon biopsies of tubular adenomas with focal malignant changes were selected from the surgical pathology file of Asan Medical Center, Seoul, Korea, following the guidelines of the Institutional Review Board. Polyps were incidentally detected in the sigmoid colon of 48-and 54-year old males who underwent colonoscopic check-up without clinical symptoms. They measured 3.0 and 1.4 cm in diameter, and were completely resected at the stalk.
Polyps were fixed immediately in 10% buffered-formalin and processed routinely. After the histopathological diagnosis, additional 6-μM sections were taken from the paraffin blocks. For the sectioning and H&E staining, all the solutions were freshly made using DEPC-treated water, and the slides and instruments were autoclaved. Normal crypts, adenoma and carcinoma cells were microdissected using an AutoPix laser capture microscope system (Arcturus, Mountain View, CA).
RNA extraction and amplification. Deparaffinized sections were removed from the slides by applying 200 μl proteinase K buffer [2% SDS, 10 mM Tris-HCl (pH 8.0), 0.1 mM EDTA]. Samples were transferred into a microcentrifuge tube and incubated at 70˚C for 1 h. Then, 3 μl proteinase K (30 μg/μl, Intron Biotechnology, Songnam, Korea) was added, and incubated again at 55˚C for 1 h. RNAs were extracted with TRIzol reagents (Invitrogen, Carlsbad, CA) as described previously (15) .
First-and second-strand DNA synthesis was performed using T7dT primers and RNase H/T3N6 primers, as described previously (15) . Then the double-stranded DNA was applied to PCR amplification using T7 promoter primers (100 pM/μl, 5'-CGGCCAGTGAATTGTAATACGACTCACTATAG GCG-3') and T3 promoter primers (100 pM/μl, 5'-GCGCG AAATTAACCCTCACTAAAGGGAGAGGG-3'). The PCR reaction was performed in a GeneAmp PCR 9600 system (PE Biosystems, Foster City, CA) for 1 min at 95˚C; 20 cycles of 30 sec at 95˚C, 40 sec at 65˚C and 5 min at 68˚C; and 7 min at 68˚C. PCR products were purified using a MinElute™ PCR purification kit (Qiagen, Valencia, CA). In vitro transcription was performed using AmpliScribe™ T7 or T3 high yield transcription kit (Epicenter, Madison, WI) at 37˚C for 5 h in 40 μl of reaction volume. Synthesized aRNA was purified using an RNeasy Mini kit (Qiagen).
cDNA microarray analysis. GenePlorer TwinChip Human-8K (Digital Genomics, Seoul, Korea) microarray chips were applied. The chips had two identical microarrays per slide, total gene spots of 8170 each. Probe labeling and hybridization were performed using the amine-modified random primer aminoallyl method as described previously (15, 18) . Either adenoma or carcinoma was labeled with Cy3 and hybridized against the same normal control labeled with Cy5. Then, the hybridization was performed as described previously (15) .
Arrays were scanned with a GenePix 4000B scanner (Axon, Foster City, CA), and images were analyzed using the GeneSight program (BioDiscovery, Los Angeles, CA). Gene spots with threshold R-value <2.0 were omitted, and a total of 7087 normalized spots (86.7%) were selected for analysis. Differentially expressed genes were analyzed using the Significance Analysis of Microarray (SAM) method, which provides the serial lists of both up-, and down-regulated genes at a given false-significance rate of choice (19) .
Results
cDNA microarray analysis of normal-adenoma-carcinoma sequence. Tubular adenomas had foci of malignant transformation with early-stage stromal invasion (Fig. 1 ). They were completely resected at the stalk, which consisted of normal colon mucosa. Crypts from normal mucosa, adenoma, and carcinomas were microdissected without stromal or inflammatory cells (Fig. 2) . From 10000 microdissected cells, approximately 70-80 μg aRNA was obtained after in vitro transcription. The expression profiles were analyzed using cDNA microarrays. After normalization, 7087 gene spots (86.7%) were selected for analysis. The complete data set is publicly available in the NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) through the accession number GSE3880. Table I . Up-regulated genes in colon polyps. Chromosome 6 open reading frame 11
Differential expression in the sequence. Hybridization data of 4 normal-adenoma and normal-carcinoma sets were analyzed using the SAM method, respectively (19) . At the expected false significance rate of 0.88%, 54 up-regulated and 471 down-regulated genes were detected in combined adenoma/ carcinoma (Fig. 3) . Up-regulated genes included ribosomal Table II . Down-regulated genes in colon polyps. (Table I) . TPR was reported to rearrange with MET oncogene upon chromosomal translocation in gastric cancers and precursor lesions (20) . Down-regulated genes included PLA2G2A, solute carrier proteins, TSPAN1, PDCD4, AATK, FCGBP, EPLIN, FABP1, AGR2, MTUS1, TSC1 and 2, galectin 4 and MT1F (Table II) . PLA2G2A has been shown to suppress APC-induced tumorigenesis in mice (21, 22) . PDCD4 and AATK have been implicated in apoptosis (23, 24) . PDCD4 has been reported to downregulate in lung, breast, colon, and prostate cancers (23) , and also in stomach cancers (11) . FCGBP is a mucin-like, non-Fc receptor protein, normally expressed in colon goblet cells (25) . Mitochondrial tumor suppressor 1 (MTUS1) and metallothionein 1F (MT1F) have been implicated in tumor suppressor activity and cancer growth inhibition (26, 27) . TSC1 and 2 are tumor suppressor genes implicated in the tuberous sclerosis complex (28) . Galectin 4 has been reported to down-regulate in colon cancers, suggesting an implication in early colorectal carcinogenesis (29) . DDX5 is an RNA helicase which functions as a transcriptional repressor, being implicated in organ differentiation (30) .
----------------------------------------------------------------------------------------------------proteins, IER3, DDX21, RECQL4, AHCY, SORD, DDAH2, transketolase and TPR

Pattern analysis of differentially expressed genes in the sequence.
We then analyzed the step-wise changes in normaladenoma-carcinoma sequence. In comparison with adjacent normal crypts, tubular adenoma showed 422 up-, and 16 down-regulated genes at the expected false significance rate 0.66%. In comparison with adenoma, carcinoma showed 20 up-, and 455 down-regulated genes at the expected false significance rate 0.16%. Genes with differential expression were categorized into 9 groups according to the patterns in the normal-adenoma-carcinoma sequence as described in Materials and methods.
The group of genes that show significant up-regulation in carcinoma but not in adenoma might be implicated in the process of malignant transformation. This group included TGF-ß2 and matrix metalloproteinase 23B (Table III) . TGF-ß signaling controls diverse cellular responses and has been implicated in various cancers (31) . Matrix metalloproteinases have been associated with cancer invasiveness (32) .
Twenty-one genes showed continuous down-regulation in the normal-adenoma-carcinoma sequence, including PLA2G2A,
FCGBP, SLC26A2, EPLIN, TSPAN1, PDCD4, PEX1, MTUS1, FABP1, DDX5, HLA-DQA1, AGR2, MT1F and galectin 4.
Many genes have been reported to have tumor suppressor/ proapoptotic activities as described above. It was of interest that down-regulation of HLA-DQA1 has also been described by Nosho et al using fresh tissue samples of colon polyps without signal amplification (10) . It has been implicated in Table III . Genes up-regulated in cancer but not in adenoma. Figure 3 . SAM analysis of colon polyps microdissected from formalin-fixed biopsies. At the expected false significance rate of 0.88%, 54 up-regulated and 471 down-regulated genes were detected in colon polyps compared to normal mucosa crypts. gastritis and gastric cancer (33) , although the pathobiological role in colon carcinogenesis is not clear.
-----------------------------------------------------------------------------------------------------Symbol Title Unigene ID GenBank ID -----------------------------------------------------------------------------------------------------
Overlapping in the sequences of the colon and stomach. We then compared the differentially expressed genes with those in the adenoma-carcinoma sequence of the stomach similarly studied in our previous study (the complete data set is publicly available at NCBI GEO, accession numbers GSM20670-5) (15). Numerous up-regulated genes overlapped in the colon and stomach sequence, including ribosomal proteins and TPR (Table IV) . Overlapping down-regulated genes included TSPAN1, FABP1 and AGR2, the pathobiological roles of which were not clear.
Discussion
We have shown the sequential expression change in the normal-adenoma-carcinoma sequence in the colon using microdissected cells from polyps with foci of malignant transformation. To our knowledge, this is the first report of the expression profiling in the colon adenoma-carcinoma sequence using microdissected cells. Differentially expressed genes were grouped according to the patterns of expression change, which might suggest pathobiological roles in the sequence. Table IV . Overlapping genes between the adenoma/carcinoma sequences in the colon and stomach. 
The expression profiling of microdissected cells has evident advantages in the analysis of subtle pathologic changes in continuity such as the adenoma-carcinoma sequence excluding the contamination of other cell types. On the other hand, a potential risk of the procedure-induced data noise should be weighed against the advantage. Nonetheless, several lines of evidence support the general applicability of our approach. Previously, we showed good correlation coefficients with fresh tissue counterparts using the same procedure (15) . Also, the data recovery rate, 86.7% hybridization in all gene spots, was reasonably high. Furthermore, coinciding data was shown in other reports in which fresh samples were used without amplification. For instance, HLA-DQA1 was also reported to be down-regulated in colon adenomas (10) . Similarly, genes such as PDCD4, SEPP1, TSNAX and IGLJ3 were also downregulated in our previous expression profiling study of stomach cancer without amplification (11) .
PLA2G2A is one of the most extensively studied genes for tumorigenesis in the colon. It was first identified in mice as a chromosomal deletion mutant which modified the tumorigenesis caused by germ-line mutation of the Apc gene, Mom-1 (modifier of min-1) (34). Mom-1 was soon revealed to be PLA2G2A (21) , which played a central role in the cytokineinduced release of arachidonic acid (35) . Later, PLA2G2A was shown to suppress APC-induced tumorigenesis in mice (22, 36) . However, the pathobiological role in human colon cancer has been controversial as no coding sequence mutation was reported (37, 38) . On the other hand, PLA2G2A has been shown to down-regulate in the majority of colon cancers (39, 40) , suggesting its implication in human colon cancers. Our report of the continuous down-regulation of PLA2G2A in the adenoma-carcinoma sequence strongly supports its implication in the tumorigenesis and carcinogenesis of the colon. It is suggested that the transcriptional regulation of PLA2G2A might be of pathobiological significance in the adenoma-carcinoma sequence. PLA2G2A has been associated with prolonged survival in stomach cancers (41) .
One of the advantages of microdissection-expression profiling is the sequential analysis at multiple transition points of disease progression. In this study, we analyzed 3 phases (2 transition points), resulting in grouping of differentially expressed genes into 9 groups according to the patterns of expression change. Such grouping based on sequential expression changes would facilitate the sorting of candidates for 'meaningful' genes in the functional genomics of cancer in vivo. More phases could be analyzed such as different grades of dysplasia, stromal invasion, or metastasis in various organs. This unique opportunity could also be applied to the analysis of pathogenetic steps and/or progression of other diseases in vivo.
The detection of multiple differentially expressed genes in the sequence suggests a complex molecular carcinogenesis in the colon. It is of interest that the sequential expression changes in the colon partly overlapped with those in the stomach (15) . Our data suggests that the adenoma-carcinoma sequences in the colon and stomach might share certain common characteristics of carcinogenesis. Further analyses of differential expression in detailed pathological steps of carcinogenesis and cancer progression are required.
